The development, incidence and treatment trends of trochanteric fractures in Germany: a cohort study.
Epidemiology
Incidence
Osteosynthesis
Trauma
Trochanteric fractures
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
10 Jul 2023
10 Jul 2023
Historique:
received:
04
03
2023
accepted:
04
07
2023
medline:
12
7
2023
pubmed:
11
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Hip fractures are a major public health problem worldwide and can lead to disability, increased mortality, and reduced quality of life. We aim to provide a nationwide epidemiological analysis of trochanteric and subtrochanteric fractures and their respective surgical treatments. Data were retrieved from the national database of the German Department of the Interior. ICD-10-GM and OPS data from the period of 2006 to 2020 were analysed and all patients with trochanteric and subtrochanteric fractures as their main diagnosis, who were treated in a German hospital, were included. Patients were grouped by age and gender and linear regression was performed where suitable to calculate statistically significant correlations between variables and incidences. 985,104 pertrochanteric fractures and 178,810 subtrochanteric fractures were reported during the analysed period. We calculated a mean incidence of 80.08 ± 6.34 for pertrochanteric and 14.53 ± 1.50 for subtrochanteric fractures per million inhabitants. In both fracture types, a distinct dependence of incidence on age can be determined. Incidence rates equally rise in both sexes through the age groups with an increase of about 288-fold from those under the age of 60 to those over the age of 90 in pertrochanteric fractures, and about 123-fold in subtrochanteric fractures. Intramedullary nailing was the most common kind of treatment for both fracture types with augmentative cerclages on the rise throughout the whole period. Plate and dynamic compression screws were decreasing in frequency over the analysed period in both fractures. We provided incidence data on per- and subtrochanteric fractures and their treatment. We calculated an economic impact of approximately 1.563 billion € per year in Germany. With regards to recent literature on costs of treatment and our findings regarding the implementation and utilization of different treatment methods, we conclude that the reinforcement of nationwide prevention programs is a relevant step in lessening the economic burden. We welcome the increased utilisation of intramedullary nailing as many studies show beneficiary outcomes and cost effectiveness in most of the included fracture types.
Sections du résumé
BACKGROUND
BACKGROUND
Hip fractures are a major public health problem worldwide and can lead to disability, increased mortality, and reduced quality of life. We aim to provide a nationwide epidemiological analysis of trochanteric and subtrochanteric fractures and their respective surgical treatments.
METHODS
METHODS
Data were retrieved from the national database of the German Department of the Interior. ICD-10-GM and OPS data from the period of 2006 to 2020 were analysed and all patients with trochanteric and subtrochanteric fractures as their main diagnosis, who were treated in a German hospital, were included. Patients were grouped by age and gender and linear regression was performed where suitable to calculate statistically significant correlations between variables and incidences.
RESULTS
RESULTS
985,104 pertrochanteric fractures and 178,810 subtrochanteric fractures were reported during the analysed period. We calculated a mean incidence of 80.08 ± 6.34 for pertrochanteric and 14.53 ± 1.50 for subtrochanteric fractures per million inhabitants. In both fracture types, a distinct dependence of incidence on age can be determined. Incidence rates equally rise in both sexes through the age groups with an increase of about 288-fold from those under the age of 60 to those over the age of 90 in pertrochanteric fractures, and about 123-fold in subtrochanteric fractures. Intramedullary nailing was the most common kind of treatment for both fracture types with augmentative cerclages on the rise throughout the whole period. Plate and dynamic compression screws were decreasing in frequency over the analysed period in both fractures.
CONCLUSIONS
CONCLUSIONS
We provided incidence data on per- and subtrochanteric fractures and their treatment. We calculated an economic impact of approximately 1.563 billion € per year in Germany. With regards to recent literature on costs of treatment and our findings regarding the implementation and utilization of different treatment methods, we conclude that the reinforcement of nationwide prevention programs is a relevant step in lessening the economic burden. We welcome the increased utilisation of intramedullary nailing as many studies show beneficiary outcomes and cost effectiveness in most of the included fracture types.
Identifiants
pubmed: 37430277
doi: 10.1186/s13018-023-03981-5
pii: 10.1186/s13018-023-03981-5
pmc: PMC10331963
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
491Informations de copyright
© 2023. The Author(s).
Références
Arch Osteoporos. 2022 Aug 31;17(1):119
pubmed: 36044096
J Am Med Dir Assoc. 2011 Oct;12(8):556-564
pubmed: 21450227
Hip Pelvis. 2020 Sep;32(3):119-124
pubmed: 32953703
Clin Interv Aging. 2013;8:697-702
pubmed: 23788832
J Bone Joint Surg Am. 2014 Oct 1;96(19):1612-20
pubmed: 25274786
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):802-8
pubmed: 23703501
Healthcare (Basel). 2021 Jun 10;9(6):
pubmed: 34200873
J Korean Med Sci. 2013 Sep;28(9):1378-81
pubmed: 24015046
Injury. 2017 Apr;48(4):819-824
pubmed: 28283181
Drugs Aging. 2008;25(6):521-9
pubmed: 18540690
Bone. 1996 Jan;18(1 Suppl):77S-86S
pubmed: 8717551
Acta Orthop. 2014 Feb;85(1):1
pubmed: 24171676
Eur J Med Res. 2021 Aug 4;26(1):86
pubmed: 34348796
Br J Hosp Med (Lond). 2020 Aug 2;81(8):1-10
pubmed: 32845763
BMJ. 2002 Feb 16;324(7334):375-6
pubmed: 11850353
Arch Osteoporos. 2014;9:182
pubmed: 24847682
Injury. 2011 Aug;42(8):727-9
pubmed: 21723444
Curr Osteoporos Rep. 2008 Dec;6(4):155-61
pubmed: 19032926
Injury. 2018 Aug;49(8):1458-1460
pubmed: 29699731
J Bone Joint Surg Br. 2011 Jun;93(6):806-10
pubmed: 21586781
J Bone Miner Res. 2012 Dec;27(12):2544-50
pubmed: 22836783
Age Ageing. 2017 Mar 1;46(2):324-328
pubmed: 27810855
Scott Med J. 2014 Feb;59(1):30-4
pubmed: 24424464
Singapore Med J. 2017 May;58(5):253-257
pubmed: 26915390
Maturitas. 2013 May;75(1):22-8
pubmed: 23434262
Gesundheitswesen. 2007 Nov;69(11):601-6
pubmed: 18080931
BMC Geriatr. 2016 Apr 01;16:75
pubmed: 27038629
Arch Intern Med. 2006 Oct 23;166(19):2124-31
pubmed: 17060543
BMC Musculoskelet Disord. 2018 Oct 12;19(1):369
pubmed: 30314495
Acta Orthop. 2009 Aug;80(4):413-5
pubmed: 19568963
Injury. 2015 Oct;46(10):1992-5
pubmed: 26264881
Calcif Tissue Int. 2019 Dec;105(6):582-588
pubmed: 31482193
J Biomech Eng. 1996 Nov;118(4):575-8
pubmed: 8950662
Calcif Tissue Int. 2013 Jan;92(1):42-9
pubmed: 23135744
J Bone Miner Res. 1996 Aug;11(8):1043-51
pubmed: 8854239
JB JS Open Access. 2019 Feb 27;4(1):e0045
pubmed: 31161153
Osteoporos Int. 2011 Oct;22(10):2575-86
pubmed: 21484361
Curr Orthop Pract. 2017 Nov;28(6):580-585
pubmed: 29177024
J Aging Res. 2011;2011:532079
pubmed: 21941655
PLoS One. 2021 Feb 16;16(2):e0246956
pubmed: 33592046
JAMA Intern Med. 2020 Sep 1;180(9):1225-1231
pubmed: 32730556
BMJ. 2011 Jun 21;342:d3304
pubmed: 21693526
Int Orthop. 2021 May;45(5):1329-1336
pubmed: 32918572
Rev Bras Ortop. 2017 Nov 08;53(4):477-481
pubmed: 30027082
Arch Bone Jt Surg. 2016 Jan;4(1):23-8
pubmed: 26894214
Bone Miner. 1994 Sep;26(3):209-18
pubmed: 7819828
Dtsch Arztebl Int. 2021 Oct 8;118(40):665-669
pubmed: 34140088
Am J Lifestyle Med. 2017 Nov 28;12(2):107-112
pubmed: 30283246
Bone Joint J. 2022 Feb;104-B(2):274-282
pubmed: 35094569
Lancet Healthy Longev. 2021 Sep;2(9):e580-e592
pubmed: 34723233
Clin Interv Aging. 2021 Jan 27;16:177-185
pubmed: 33542622
Injury. 2018 Dec;49(12):2161-2166
pubmed: 30526922
Minerva Med. 2014 Aug;105(4):275-81
pubmed: 24867188
Inj Prev. 2011 Dec;17(6):365-70
pubmed: 21486987
Ther Adv Chronic Dis. 2015 Jul;6(4):185-93
pubmed: 26137208
Sci Rep. 2022 Jun 3;12(1):9270
pubmed: 35661791
Osteoporos Int. 2005 Dec;16(12):1475-80
pubmed: 16217587
BMC Musculoskelet Disord. 2010 Mar 11;11:48
pubmed: 20222965
Physiother Can. 2008 Fall;60(4):358-72
pubmed: 20145768
Br J Clin Pharmacol. 2017 Oct;83(10):2292-2302
pubmed: 28589543
Calcif Tissue Int. 1999 Sep;65(3):183-7
pubmed: 10441647